A systematic review and meta-analysis of randomized controlled trials on the effects of magnesium supplementation on insulin sensitivity and glucose control
AMG 133 (now known as maridebart cafraglutide) is an optimized GIPR/GLP-1R bispecific molecule engineered by conjugating a fully human monoclonal anti-human GIPR-Ab with two GLP-1 analogue agonist peptides using amino acid linkers
Fischman CM, Udey MC, Kurtz M, Wedner HJ
With the right structure in place, most patients experience noticeable changes not just on the scale, but in their daily life
A.ShokhirevM
In addition, many cardiologists think prescribing GLP-1 RAs should be the domain of endocrinologists, even though there is an unequivocal body of evidence demonstrating cardiovascular efficacy, and recommendations for prescription are now in every guideline and professional society recommendation for cardiology, which parallel the recommendations from endocrinology and primary care societies